About this document
Dom 28 1013 by virtudigilab.datek is a document available to read on EtoBox.
This study investigates ethnic differences in the effectiveness of second-line type 2 diabetes medications (sulfonylureas, DPP4 inhibitors, and SGLT2 inhibitors) on cardiovascular outcomes. Among 91,116 individuals, the findings suggest a greater effect of DPP4 inhibitors on major adverse cardiovascular events in Black individuals compared to White and South Asian groups, particularly regarding heart failure hospitalizations. Overall, there was limited evidence of ethnic differences in treatment effects for
- Author
- virtudigilab.datek
- Language
- EN